Washington—Physicians who are considering prescribing a new drug or device or recommending a surgical procedure depend for assurance of efficacy on the published results of high-quality clinical trials. Unfortunately, all too often the trials are inadequate, said Joel J. Nobel, MD, speaking at a workshop held last month by the Institute of Medicine (IOM) on medical device innovation. Nobel is president of ECRI, headquartered in Plymouth Meeting, Pa, a widely recognized, nonprofit health services research agency focusing on health care technologies and quality.
Marwick C. Adequacy of Clinical Trials Questioned at IOM Meeting. JAMA. 2000;283(11):1411-1412. doi:10.1001/jama.283.11.1411-JMN0315-4-1